Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells

Free Radic Biol Med. 2001 Dec 1;31(11):1473-85. doi: 10.1016/s0891-5849(01)00726-2.

Abstract

We examined the acute toxicity of dieldrin, a possible environmental risk factor of Parkinson's disease, in a dopaminergic cell model, PC12 cells, to determine early cellular events underlying the pesticide-induced degenerative processes. EC(50) for 1 h dieldrin exposure was 143 microM for PC12 cells, whereas EC(50) for non-dopaminergic cells was 292-351 microM, indicating that dieldrin is more toxic to dopaminergic cells. Dieldrin also induced rapid, dose-dependent releases of dopamine and its metabolite, DOPAC, resulting in depletion of intracellular dopamine. Additionally, dieldrin exposure caused depolarization of mitochondrial membrane potential in a dose-dependent manner. Flow cytometric analysis showed generation of reactive oxygen species (ROS) within 5 min of dieldrin treatment, and significant increases in lipid peroxidation were also detected following 1 h exposure. ROS generation was remarkably inhibited in the presence of SOD. Dieldrin-induced apoptosis was significantly attenuated by both SOD and MnTBAP (SOD mimetic), suggesting that dieldrin-induced superoxide radicals serve as important signals in initiation of apoptosis. Furthermore, pretreatment with deprenyl (MAO-inhibitor) or alpha-methyl-L-p-tyrosine (TH-inhibitor) also suppressed dieldrin-induced ROS generation and DNA fragmentation. Taken together, these results suggest that rapid release of dopamine and generation of ROS are early cellular events that may account for dieldrin-induced apoptotic cell death in dopaminergic cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / analysis
  • Animals
  • Apoptosis / drug effects*
  • Cell Survival / drug effects
  • Chromatography, High Pressure Liquid
  • Dieldrin / administration & dosage
  • Dieldrin / toxicity*
  • Dopamine / metabolism
  • Dopamine / physiology*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Flow Cytometry
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / physiology
  • L-Lactate Dehydrogenase / analysis
  • L-Lactate Dehydrogenase / metabolism
  • Lipid Peroxidation
  • Membrane Potentials / drug effects
  • Mitochondria / drug effects
  • Mitochondria / physiology
  • Mitochondria / ultrastructure
  • Monoamine Oxidase Inhibitors / pharmacology
  • Oxidative Stress / drug effects*
  • PC12 Cells
  • Parkinson Disease, Secondary / chemically induced
  • Rats
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase / pharmacology
  • Tyrosine 3-Monooxygenase / antagonists & inhibitors

Substances

  • Enzyme Inhibitors
  • Monoamine Oxidase Inhibitors
  • Reactive Oxygen Species
  • 3,4-Dihydroxyphenylacetic Acid
  • L-Lactate Dehydrogenase
  • Tyrosine 3-Monooxygenase
  • Superoxide Dismutase
  • Dieldrin
  • Dopamine